SESN
Closed
Sesen Bio Inc
0.6288
+0.6288 (0%)
Last Update: 08 Mar 2023 00:00:00
Yesterday: 0.
Day's Range: 0. - 0.
Send
sign up or login to leave a comment!
When Written:
0.6288
Sesen Bio Inc. is a clinical-stage biopharmaceutical company that focuses on developing targeted fusion protein therapies for the treatment of cancer. The company's lead product candidate is Vicinium, which is a fusion protein that targets and destroys cancer cells. Vicinium is currently in clinical trials for the treatment of high-grade non-muscle invasive bladder cancer. Sesen Bio Inc. is headquartered in Cambridge, Massachusetts, and was founded in 2008. The company is publicly traded on the NASDAQ stock exchange under the ticker symbol "SESN."
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








